Bristol Myers Squibb Derivative Contract Liabilities (Quarterly) Analysis

Bristol Myers Squibb Co. (BMY)

61.60 +0.35 (+0.57%) USD | NYSE | Feb 24, 16:00

61.62 +0.02 (+0.03%) Pre-Market: 08:41

View Derivative Contract Liabilities (Quarterly) for BMY.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Derivative Contract Liabilities (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Derivative Contract Liabilities (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Derivative Contract Liabilities (Quarterly) Benchmarks

Start Trial

Amgen, Inc.	--
Gilead Sciences, Inc.	--
Regeneron Pharmaceuticals, Inc.	--
Janux Therapeutics, Inc.	--
Moderna, Inc.	--